RxDoctor Payments Data

Karim Halazun, MD

Transplant Surgery · New York, NYNPI 1326208976

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 73.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $21,227, more than ten times the $203 reported in 2019.

$27,965in general payments, 2019–2025

Across 37 payments — averaging $755.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$20K
  • Transmedics, Inc.$6K
  • Paragonix Technologies, Inc.$397
  • Medtronic$185
  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$179
  • Intuitive Surgical$143
  • plus $454 from 6 others

What the payments were for

  • Consulting fees$1,5005%
  • Speaking & faculty fees$14,01850%
  • Travel & lodging$8,51630%
  • Food & beverage$3,93214%

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,965 in reported general payments places this provider in the 85th percentile of 72 transplant surgery providers in New York.

See all transplant surgery providers in New York

Medicare billing

Part B allowed, 2024
$96,604
Medicare patients
47
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →